Tenapanor Scores FDA Advisory Committee Endorsement Tenapanor Scores FDA Advisory Committee Endorsement

An FDA advisory committee said the benefits of tenapanor for treating hyperphosphatemia in patients on dialysis outweighed its risks as both mono- and combo-therapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news